Supplementary Table S1 from Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial

2026 Open access

Read full text
Authors: Deaglan Joseph McHugh, Matthew C. Dallos, Min Yuen Teo, Sean M. McBride, Anuradha Gopalan, Andrea Arfè, Christopher Gaffney, Mehak Amjed, Patrick J. McCann, Hannah Benoliel, Karen A. Autio, A Goh
+22 more Kevin M DeRudder, Catherine J. Ryan, Russell Zelig Szmulewitz, Alicia Katherine Morgans, Glenn J. Bubley, Shilpa Gupta, Eric A. Klein, Paul L. Nguyen, Adam S. Kibel, Andrew A. Wagner, I.D. Kaplan, Scott E. Eggener, David Johnson Einstein, Andres Martin Acosta, Rahul D. Tendulkar, David James VanderWeele, William J. Catàlona, Sean Sachdev, Stanley L. Liauw, Jeff Eastham, Mary‐Ellen Taplin, Howard I. Scher
DOI: 10.1158/1078-0432.31248943
Cited by: 0

Abstract

Supplementary Table 1. Representativeness of Study Participants

Fields of Study & Subjects

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Bone health and treatments

Publication details

Publication date
4 February 2026